WallStSmart

Kellanova (K)vsArcadia Biosciences Inc (RKDA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kellanova generates 266188% more annual revenue ($12.67B vs $4.76M). K leads profitability with a 0.1% profit margin vs -195.9%. K earns a higher WallStSmart Score of 50/100 (C-).

K

Buy

50

out of 100

Grade: C-

Growth: 3.3Profit: 4.0Value: 4.3Quality: 5.3
Piotroski: 5/9Altman Z: 2.20

RKDA

Hold

38

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 6.7Quality: 5.3
Piotroski: 3/9Altman Z: -62.62
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for K.

RKDAUndervalued (+37.9%)

Margin of Safety

+37.9%

Fair Value

$2.80

Current Price

$1.03

$1.77 discount

UndervaluedFair: $2.80Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

K0 strengths · Avg: 0/10

No standout strengths identified

RKDA2 strengths · Avg: 9.0/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

EPS GrowthGrowth
28.5%8/10

Earnings expanding 28.5% YoY

Areas to Watch

K4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Return on EquityProfitability
0.3%3/10

ROE of 0.3% — below average capital efficiency

Profit MarginProfitability
0.1%3/10

0.1% margin — thin

Operating MarginProfitability
0.1%3/10

Operating margin of 0.1%

RKDA4 concerns · Avg: 2.5/10
Market CapQuality
$1.94M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-323.1%2/10

ROE of -323.1% — below average capital efficiency

Revenue GrowthGrowth
-8.3%2/10

Revenue declined 8.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : K

K has a balanced fundamental profile.

Bull Case : RKDA

The strongest argument for RKDA centers on Price/Book, EPS Growth.

Bear Case : K

The primary concerns for K are Revenue Growth, Return on Equity, Profit Margin. Thin 0.1% margins leave little buffer for downturns.

Bear Case : RKDA

The primary concerns for RKDA are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

K profiles as a value stock while RKDA is a turnaround play — different risk/reward profiles.

RKDA carries more volatility with a beta of 0.50 — expect wider price swings.

K is growing revenue faster at 0.0% — sustainability is the question.

K generates stronger free cash flow (359M), providing more financial flexibility.

Bottom Line

K scores higher overall (50/100 vs 38/100). RKDA offers better value entry with a 37.9% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kellanova

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

The Kellogg Company, doing business as Kellogg's, is an American multinational food manufacturing company headquartered in Battle Creek, Michigan, United States.

Arcadia Biosciences Inc

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Arcadia Biosciences, Inc. is dedicated to developing various crop productivity traits primarily in hemp, wheat, and soybeans. The company is headquartered in Davis, California.

Visit Website →

Want to dig deeper into these stocks?